On the other hand, in cancer, RAS was proven to have the capacity to induce disruption of adherent junctions but not tight junctions (Zonula occludens-1 or ZO-1 and occludin) or desmosomal component desmoplakin, while being interconnected with ERK1/2 and PI3K [75]. The gene discussed is MAPK3; the disease is cancer.